1,962 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·HER2 CISH PHARMDX KIT
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·HER2 CISH pharmDx Kit
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·HER2 CISH PHARMDX KIT
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA Pre-Market Approval
FDA Class 3
·DAKO EGFR PHARMDX KIT
System, Photopheresis, Extracorporeal
FDA Pre-Market Approval
FDA Class 3
·Therakos Cellex Procedural Kit
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Stimulator, Spinal-Cord, Totally Implanted For Pain Relief
FDA Pre-Market Approval
FDA Class 3
·EON WALL CHARGER KIT
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·THxID-BRAF assay kit
Permanent Defibrillator Electrodes
FDA Pre-Market Approval
FDA Class 3
·SELECTSECURE LEAD/SLEEVE KIT
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·HER2 CISH PHARMDX KIT
System, Test, Her-2/Neu, Nucleic Acid Or Serum
FDA Pre-Market Approval
FDA Class 3
·HER2 FISH PHARMDX KIT
Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
FDA Pre-Market Approval
FDA Class 3
·AUTODELFIA HAFP TEST KIT
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·HER2 CISH PHARMDX KIT
System, Test, Tumor Marker, For Detection Of Bladder Cancer
FDA Pre-Market Approval
FDA Class 3
·NMP22 BLADDERCHEK TEST KIT
System, Photopheresis, Extracorporeal
FDA Pre-Market Approval
FDA Class 3
·Therakos CELLEX Photopheresis Kit
System, Photopheresis, Extracorporeal
FDA Pre-Market Approval
FDA Class 3
·Therakos CELLEX Procedural Kit
Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence
FDA Pre-Market Approval
FDA Class 3
·UROVYSION BLADDER CANCER KIT
Pump, Infusion, Implanted, Programmable
FDA Pre-Market Approval
FDA Class 3
·MODEL 855 REFILL KIT
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
FDA Pre-Market Approval
FDA Class 3
·ABBOTT HBE DIAGNOSTIC KIT
System, Test, Tumor Marker, For Detection Of Bladder Cancer
FDA Pre-Market Approval
FDA Class 3
·NMP22 BLADDERCHEK TEST KIT